NPC1L1 and infection: Given that NPC1L1 is described as the main target of ezetimibe in humans, the profile of gene transcription of NPC1L1 was estimated over infection kinetics (3–24 h p. i.)on T. gondii-, N. caninum- and B. besnoiti-infected BUVEC by qRT-PCR.